Flowserve heads into its third-quarter report with an unusual split personality. Last quarter, orders jumped 26% to $1.35 billion, aftermarket bookings set a record and margins kept climbing, yet sales slipped and management trimmed its full-year revenue outlook because equipment bound for the Middle East was sitting on loading docks. The market has sided with the cautious half of that story, and the October 28 report, due after the close, is the first real chance to show that strong orders are turning into shipments.
The Street expects earnings of $0.98 per share on revenue of about $1.24 billion. That is roughly 9% earnings growth and nearly 6% revenue growth from a year ago, a clear step up from the second quarter, when reported sales fell 2% and organic sales fell 3%. Part of that lift reflects the Trillium valve business, which closed June 30 and now adds to the top line. Management has also said it expects organic sales to grow about 5% in the second half, so this quarter should show whether that rebound is underway. The whisper number of $1.02 sits a few cents above consensus. The gap is small, but it hints that some investors expect the company's habit of steady margin gains to produce a modest beat.
Guidance is the more interesting comparison. Flowserve raised the bottom of its 2026 earnings range to $4.05 to $4.20, while the full-year consensus of $4.04 sits just below that new floor. In other words, analysts are not fully buying management's confidence. A third quarter in line with or ahead of expectations, paired with a reaffirmed range, would narrow that gap. Any slip toward the low end would suggest the Street's caution was justified.
Operationally, three issues matter most. The first is the Middle East. Management called the conflict roughly a 3 percentage point drag on organic growth so far this year, with run-rate business in the region down about 20%, and it assumed that pressure would last through the second half. Signs that customers are accepting deliveries, or that the roughly $50 million rebuild opportunity is starting to take shape, would support the view that this is a timing problem rather than lost demand. Further project slippage into 2027 would undercut it. The second is the flow control division, whose adjusted operating margin fell to 12.6% from nearly 20% two quarters earlier as valve volumes in the region disappeared. A recovery there, plus early 80-20 margin benefits from Trillium, would make the company's goal of about 16% adjusted operating margin for the year look solid. The third is whether bookings hold up. One standout quarter of orders, driven by LNG awards in Canada and the Middle East and more than $110 million in nuclear orders, needs a follow-up showing a book-to-bill ratio above 1 and continued aftermarket strength near $700 million.
The stock tells a story of skepticism. Shares have fallen 4% since the last report, while the S&P 500 gained about 4%. At $70.50, the stock trades below its 200-day moving average of $76.37 and only about 3% above its post-earnings low of $68.36, far from the $83.35 high. Sentiment has also turned slightly more bearish than it was heading into the last report. Together, these suggest expectations are restrained, which lowers the bar somewhat if the results are clean.
The central question is conversion. Flowserve has built a convincing case on orders, backlog and margins, but that case depends on product actually shipping and the valve business regaining its footing. If revenue reaccelerates and the flow control division's margins recover, the improving story from last quarter stays intact and the full-year range looks conservative. If the Middle East keeps product stuck and sales stall again, the stock's recent weakness will look less like an overreaction and more like an early warning.